Regulatory bodies, including the FDA and EMA, require comprehensive immunogenicity testing during clinical development, including method validation, sample handling, and data traceability
Frequently asked questions We know managing your health can feel complex, so weve answered a few of the most common questions
On the basis of various factors, such as the concentration of active ingredients or the patient's condition, the combination according to the invention can be marketed as a food supplement, a nutritional supplement, or as a therapeutic product on sale with or without a compulsory doctor's prescription
PT-141 (libido) works within 3060 minutes of administration
Increased FUS levels in astrocytes leads to astrocyte and microglia activation and neuronal death
First, the reassuring part